Skip to main content
OpenTrials

Clinical trial condition

Graft vs Host Disease

Explore clinical trials studying Graft vs Host Disease. Study availability and eligibility vary by location and protocol.

471 public trials 73 recruiting studies
Refine in advanced search Browse all conditions

Graft vs Host Disease trial results

Recruiting

A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant

NCT07006506

Conditions
Graft Versus Host Disease, Graft vs Host Disease, Hematologic Diseases, +6 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk-Commack (Limited protocol activity) Commack, New York, United States
View Trial Details
Recruiting

A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)

NCT04710576

Conditions
Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +9 more
Locations
  • University of Alabama at Birmingham - Children's of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • City of Hope Duarte, California, United States
  • University of Southern California Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 121 locations
View Trial Details
Recruiting

Study of Efficacy and Safety of Ruxolitinib in Chinese Participants With Corticosteroid-refractory Chronic Graft vs. Host Disease

NCT06824103

Conditions
Chronic Graft vs. Host Disease, Corticosteroid-refractory Chronic Graft vs. Host Disease, Graft vs Host Disease, +2 more
Locations
  • Novartis Investigative Site Hefei, Anhui, China
  • Novartis Investigative Site Guangzhou, Guangdong, China
  • Novartis Investigative Site Guangzhou, Guangdong, China
  • Novartis Investigative Site Nanning, Guangxi, China
View all 22 locations
View Trial Details
Recruiting

Letermovir Prophylaxis Duration Guided by CMV-Specific T-cell Monitoring After Allo-HSCT.

NCT07569653

Conditions
Cytomegalovirus Disease, Cytomegalovirus Infections, DNA Virus Infections, +6 more
Locations
  • Chinese PLA General Hospital Beijing, Beijing Municipality, China
  • The Second Hospital of Hebei Medical University Shijiazhuang, Hebei, China
  • Henan Cancer Hospital Zhengzhou, Henan, China
  • The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China
View Trial Details
Recruiting

A Study of Photobiomodulation (PBM) Therapy in People With Oral Graft-Versus-Host Disease (GVHD) After Stem Cell Transplant

NCT05675930

Conditions
GVHD, Graft vs Host Disease, Graft-Versus-Host Disease, +2 more
Locations
  • National Institute of Health (Data Collection AND Specimen Analysis) Bethesda, Maryland, United States
  • Memorial Sloan Kettering at Basking Ridge (Consent only) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Consent only) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Bergen (Consent only) Montvale, New Jersey, United States
View Trial Details

Related conditions